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and response to renal ischemia reperfusion injury (Nadella et al., 2010; Regner et al., 2011; Kwon et al., 2012) , cardiovascular regulation (Blumer et al., 2008; Chauhan et al., 2012) , lysosomal biogenesis and bacterial infection (Vural et al., 2015) , and chemokine signal processing including leukocyte chemotaxis (Kamakura et al., 2013; Branham-O'Connor et al., 2014; Singh et al., 2014) . The immune system in particular requires dynamic signal processing and spatially integrated G-protein signaling including the use of accessory proteins (e.g. (Moratz et al., 2000; Moratz et al., 2004; Han et al., 2005; Han et al., 2006; Hwang et al., 2013; Boularan and Kehrl, 2014; Branham-O'Connor et al., 2014; Huang et al., 2014; Boularan et al., 2015; Hwang et al., 2015) . AGS4 (gene name: G-protein signaling modulator 3 (Gpsm3)) contains three GPR motifs and is of particular interest due to its predominant expression in the immune system ((Giguere et al., 2013) , vide infra) where its expression appears to be responsive to external stimuli 1 and has been linked to autoimmune and inflammatory diseases (Nakou et al., 2008; Ahn et al., 2012; Kiliszek et al., 2012; Yan et al., 2012; Zhong et al., 2012; Kupfer et al., 2013) .
We previously demonstrated that the Gi-AGS4/Gpsm3 interaction is regulated by a cell surface 7TMR (Oner et al., 2010b; Robichaux et al., 2015) , thus providing an alternative mode of input to heterotrimeric G-proteins, which may compliment and/or extend canonical receptor -G-protein -effector signaling systems. However, regulation of Gi-AGS4 complex by chemokine receptors and the functional consequence of such regulation and its impact on chemokine-regulated G-protein signal processing is unknown. As part of an expanded approach to define the functional roles of AGS4/Gpsm3
in vivo, we utilized AGS4/Gpsm3-null mice with an initial investigation into the role of AGS4 in chemoattractant signal processing. Our data indicate that AGS4/Gpsm3 plays an important role in processing signals emanating from chemoattractant receptors that regulate leukocyte motility, thus further expanding the functional roles of G-protein signal modulators in the immune system.
MATERIALS AND METHODS
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JPET Fast Forward. Published on January 6, 2017 as DOI: 10.1124/jpet.116.238436 at ASPET Journals on January 7, 2017 jpet.aspetjournals.org Mouse models -Gpsm3 -/-mice generated in the C57BL/6 background were obtained through the Briefly, 5' and 3' homology arms (6260bp comprising exon 1 of Gpsm3 and surrounding regions and 4155bp, consisting of Gpsm3 exon 4 and surrounding regions, respectively) flanking a floxed neomycinresistance cassette and promotorless lacZ was inserted into genomic Gpsm3 by homologous recombination. Genotyping of mice was performed with a three-primer polymerase chain reaction (PCR) design using a forward primer from the 5' end of the first exon of Gpsm3 (mgGpsm3 16651 forward), a second forward primer which is specific to the targeting plasmid (Common 3' forward), and a reverse primer from Gpsm3 exon 4 of the Gpsm3 coding sequence ("CSD-Gpsm3-SR1"). The primer sequences are as follows: mgGpsm3 16651 forward primer 5'-TGA CGG GTG GAC ACA GGA GAC TTG GGA AAG-3'; Common 3' forward (universal RAF5 forward) 5'-CAC ACC TCC CCC TGA ACC TGA AAThis article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on January 6, 2017 as DOI: 10.1124/jpet.116.238436 at ASPET Journals on January 7, 2017 jpet.aspetjournals.org Downloaded from 3'; CSD-Gpsm3-SR1 5'-CAG GGA AAG TGG GTG GTA AAT ACA G-3'. Using this strategy, a 1200bp band representing wild-type Gpsm3 would result from priming from mgGpsm3 16651 forward and CSD-Gpsm3-SR1, and a 776bp band representing the Gpsm3-null allele would result from priming of Common 3' forward and CSD-Gpsm3-SR1 (Figure 2A ). Wild-type and Gpsm3 -/-female littermates at 6-12 weeks of age generated from Gpsm3 +/-intercrosses were used. Tissues and lysates were prepared and processed for immunoblotting as described (Blumer et al., 2002) .
Complete Blood Count Analysis -Cardiac puncture was administered to euthanized WT or Gpsm3 -/-mice using a 1 ml syringe fitted with a 21G needle to harvest fresh blood from the left ventricle slowly to prevent cardiac collapse of the heart and subsequently collected in BD Microtainer tubes containing EDTA. Samples were maintained at constant temperature and humidity throughout processing and analysis. Complete blood cell counts (CBCs) were performed using a HemaVet 950 (Drew Scientific, Dallas, TX) instrument to measure leukocyte, erythrocyte, and thrombocyte levels in each sample.
Machine calibration and performance were verified each day that samples were analyzed using MULTI-TROL standard solution (Dog, Drew Scientific, Dallas, TX). All samples were run within 2 hr of initial collection.
Primary cells -To isolate dendritic cells, bone marrow was isolated from WT or Gpsm3 -/-mouse femurs and tibiae using a 25G syringe to flush the bone marrow out with 10 mL of DPBS (PBS, Ca ++ and Mg ++ free). Isolated bone marrow was then filtered through a 40-μm nylon cell strainer, centrifuged at 4°C 500
x g and decanted. Red blood cells were lysed with 5 mL of ice-cold ACK lysis buffer (0.17 M NH 4 Cl/0.17 M Tris) for 5 min at room temperature, followed by an additional spin at 4°C 500 x g to pellet the harvested bone-marrow cells. Isolated cells were then resuspended in 10 mL DC I media (RPMI-1640 supplemented with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and 20 ng/ml rmGM-CSF), and plated 4-5 x 10 5 cells/mL in a 10 cm tissue culture dish. On day four, 10 mL fresh DC I media was added to each dish. On day eight, non-adherent and loosely adherent cells were harvested, centrifuged 4°C 500 x g, decanted and re-seeded in 10 mL fresh DC II media (RPMI-1640 supplemented JPET #238436
with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and 10 ng/ml rmGM-CSF) to generate immature dendritic cells (iDC). Day nine cells were treated with or without 200 ng/mL LPS for the indicated times or for 24 hours to generate mature dendritic cells (mDC). To isolate splenic B-and Tlymphocytes, spleens of WT or Gpsm3 -/-mice were gently crushed between frosted glass slides in 10 mL serum-free RPMI. Spleen homogenate was centrifuged at 4°C 500 x g and decanted. Red blood cells were lysed with 10 mL of ice-cold ACK lysing buffer for 5 min at room temperature, followed by an additional spin at 4°C 500 x g to pellet the splenocytes. Splenocytes were then washed once and resuspended in DPBS supplemented with 0.1% BSA and 2 mM EDTA at 5 x 10 7 cells/mL or 1 x 10 8 cells/ml for subsequent B or T cell isolation, respectively. Cell isolation was performed according to
Invitrogen Dynabeads protocol for untouched B cell isolation or negative T cell isolation. For neutrophil isolation, bone marrow was isolated from WT or Gpsm3 -/-mouse femurs and tibiae using a 25G syringe to flush the bone marrow out with 10 mL of DPBS. Isolated bone marrow was then filtered through a 40-μm nylon cell strainer, centrifuged at 4°C 500 x g and decanted. Pelleted cells were resuspended in 2 mL DPBS followed by subsequent careful layering on top a 3-layer Percoll™ density gradient. The density gradient was generated by diluting 100% Percoll™ in DPBS to required densities represented by 78%, 64%, 52% Percoll dilutions. Stacking of the different layers was conducted as follows, 3 mL 78%
Percoll, 2 mL 64% Percoll, and 2 mL 52% Percoll followed by subsequent 2 mL of sample. After centrifugation, 1500 x g for 40 min at 4°C, the 78/64% Percoll interface was carefully isolated and added to 9 mL of DPBS to disrupt the remaining gradient. Isolated cells were then centrifuged 4°C, 1500 x g for 5 min, decanted, and subjected to 1 mL of ice-cold ACK lysis buffer for 5 min at room temperature to remove any remaining red blood cells. Cells were then resuspended in 1-2 mL phenol red-free RPMI supplemented with 0.1% BSA and 2mM EDTA.
Immunoblotting -Single-cell suspensions from spleen were prepared by crushing freshly dissected tissues between frosted glass slides in 10 mL DPBS. After centrifugation 4°C 500 x g 5 min, samples were decanted and red blood cells lysed with 10 mL ice-cold ACK lysis buffer for 5 min at room This article has not been copyedited and formatted. The final version may differ from this version.
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temperature followed a second round of centrifugation at 4°C 500 x g for 5 min. ACK lysis buffer was then decanted and pellets were resuspended in 100-300 µL 1% NP40 lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40) with protease inhibitors. Samples were incubated on ice for 20 min followed by centrifugation at 10,000 x g for 30 min at 4°C. Primary cultures of dendritic cells were harvested using cell scrappers and neutrophils were collected after Percoll density centrifugation to be processed in the 1% NP-40 lysis buffer with protease inhibitors as described above. Protein concentration was determined by a Pierce BCA protein assay. Protein samples were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 10-13.5%), then separated proteins were transferred to polyvinylidene difluoride (PVDF) membranes for immunoblotting as described (1:250 dilution) overnight 4°C, followed by three 10 min washes in TBST. Membranes were then exposed to 1:5,000 dilution of horseradish peroxidase-conjugated goat anti-rabbit IgG 30 min room temperature, followed by three 30 min washes with TBST and subsequent exposure with ECL. 
Phospho-ERK (pERK) assays -Single cell suspensions of WT and Gpsm3
Thioglycollate-induced intraperitoneal inflammation -WT and Gpsm3
-/-mice received intraperitoneal injections using an insulin syringe (28G) to deliver 1 mL of DPBS or 4% thioglycollate (in DPBS, sterilized, and aged for a minimum of 2 wks). After 2 hrs, mice were euthanized and intraperitoneal (IP) cavity lavage was carried out through injection of 10 mL cold DPBS and thorough subsequent agitation of the cavity. Blood (350 -600 µL) was also collected by cardiac puncture and bone marrow was collected from femurs as described above in Primary Cells section. Isolated cells were centrifuged 4°C
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at ASPET Journals on January 7, 2017 jpet.aspetjournals.org Downloaded from 500 x g 5 min, excess supernatant decanted, and red blood cells were lysed using 1 mL ice-cold ACK lysis buffer (5 min incubation followed by subsequent 500 x g centrifugation for 5 min). Blood samples required a minimum of two ACK lysis steps to remove all of the red blood cells. Isolated IP lavage cells were then resuspended in 50 µL of PBS with 1% BSA and 0.1% NaN 3 (PBS-BSA), isolated cells from the blood were resuspended in 200 µL of PBS-BSA, and isolated bone marrow cells were resuspended in 1 mL of PBS-BSA. Each sample then had 50 µL subjected to incubation with conjugated antibodies for analysis by flow cytometry as described below.
Flow cytometry and cell sorting -Single-cell suspensions of WT and Gpsm3 -/-neutrophils collected from Percoll density centrifugation or from thioglycollate-induced inflammation experiments were prepared as described above. Cell pellets were washed and resuspended in 50 µL PBS supplemented with 1% BSA and 0.1% NaN 3 (PBS-BSA). Cells were incubated with primary FITC-CD11b (0.3 µL, 0.15 µg) or PE-Ly-6G (2 µL, 0.4 µg) conjugated Abs or isotype controls FITC-Rat IgG2a,κ (1 µL, 0.5 µg) or PE-Rat IgG2b,κ (3 µL,0.6 µg) in PBS-BSA for 30 min at 4°C (BD Pharmingen, San Diego, CA).
Cells were washed thrice with 500 µL PBS-BSA with subsequent centrifugations 4°C 500 x g 5 min, and resuspended in 250-500 µl of PBS-BSA for analysis by flow cytometer (BD Pharmingen). Neutrophil populations were observed as being dual positive (CD11b + , Ly-6G + ).
Data Analysis -Statistical significance for differences involving a single intervention was determined by one-way analysis of variance (ANOVA) followed with a post hoc Tukey's test using GraphPad Prism version 4.03 (GraphPad Software, San Diego).
RESULTS
We previously demonstrated that the Gi-AGS4 interaction is regulated by Gi-coupled 7-TM receptors such as the  2 -adrenergric receptor (Oner et al., 2010b; Robichaux et al., 2015) . As an initial approach to determine if such regulation of Gi-AGS4 extends to chemokine receptors, which are widely interaction, indicating regulation of this complex is indeed sensitive to chemokine receptor activation ( Figure 1A ). CXCL12 regulation of the Gi 2 -AGS4 complex required the presence of CXCR4 and was blocked by the CXCR4 antagonist AMD3100 (plerixafor) and by pertussis toxin pretreatment, which ADP-ribosylates Gi and prevents receptor -G-protein coupling. BRET signals were completely absent with a mutant form of AGS4 in which a conserved glutamate residue in each of its three GPR motifs was mutated to alanine ("AGS4-Q/A"), rendering it incapable of binding Gi (Cao et al., 2004; Oner et al., 2010b) , which serves as an internal negative control for the system ( Figure 1A ).
We next sought to determine if AGS4-Gi complexes might actually interface directly with CXCR4 in an agonist-regulated manner by modifying our BRET platform to include CXCR4-Venus as the acceptor rather than Gi 2 -YFP ( Figure 1B, top panel) . In the absence of co-expressed Gi 2 , AGS4 -CXCR4 BRET signals were only slightly above background; however, when Gi 2 was co-expressed, a robust AGS4 -CXCR4 BRET signal was observed, indicating a Gi 2 -dependent tripartite complex between AGS4, Gi 2 and CXCR4 ( Figure 1B , bottom panel). This complex was also regulated by CXCL12, the affect of which was blocked by the antagonist AMD3100 (plerixafor) and pertussis toxin pretreatment ( Figure 1B) . Taken together, these data are consistent with our previous data (Oner et al., 2010b; Robichaux et al., 2015) and indicate that the AGS4-Gi module is capable of forming a complex with CXCR4 that is agonist-dependent, with broad implications on chemokine signal integration.
To further understand the functional consequence of this novel regulation and as part of an ongoing effort to define the functional roles of GPR proteins in the immune system (e.g. Genotyping and immunoblotting confirmed that the insertion of the targeting plasmid resulted in the loss of AGS4 protein expression (Figure 2A, B) .
The location of the Gpsm3 gene within the Class III MHC locus suggested that AGS4/Gpsm3 is primarily expressed in the immune system, and initial observations from us and others indicated this was indeed the case (Cao et al., 2004; Kimple et al., 2004; Zhao et al., 2010; Schmidt et al., 2012; Giguere et al., 2013) . We also discovered AGS4 expression in primary bone marrow-derived dendritic cells and splenocytes ( Figure 2B ). CBC analysis indicated that AGS4/Gpsm3-null mice exhibited a mild but significant neutropenia and lymphocytosis while other leukocyte populations were unaltered ( Figure 2C ).
As an initial approach to determine the role of AGS4 in G-protein signal processing in leukocytes, we examined chemokine-mediated activation of ERK1/2 in primary dendritic cells and splenocytes. Loss of AGS4/Gpsm3 expression resulted in a reduction in CXCL12-activated ERK1/2 phosphorylation in both populations of cells (Figure 3) , suggesting a role for AGS4 in chemokine signal processing.
In conjunction with the known role of Gi-based signaling in chemotaxis (e.g. (Rudolph et al., 1995; Han et al., 2005; Hwang et al., 2007; Zarbock et al., 2007; Cho et al., 2012; Wiege et al., 2012; Surve et al., 2016) , previous reports also indicate that ERK1/2 activation subsequent to chemokine receptor stimulation plays an important role in directed migration of leukocytes (Tilton et al., 2000; Delgado-Martin et al., 2011; Sagar et al., 2012) . To explore the possible role of AGS4/Gpsm3 in chemotaxis, we measured chemokine-directed migration in primary dendritic cells and T lymphocytes.
We observed ~25% reductions in CXCL12-directed chemotaxis in primary dendritic cells and CCL19-directed chemotaxis in primary T lymphocytes from AGS4/Gpsm3-null mice compared to WT mice ( Figure 4A ,B). There were no significant differences in random migration of primary dendritic cells and T lymphocytes from AGS4/Gpsm3-null and WT mice, indicating that the chemotactic defects in AGS4/Gpsm3-null mice was primarily directional and not due to an overall increase in migratory capacity. 2 In addition, flow cytometry analysis revealed that chemokine receptor levels were unaltered in leukocytes from AGS4/Gpsm3-null mice, thus indicating that the chemotactic defects observed were not due to the loss of chemokine receptor expression.
3
Gene expression databases indicate that AGS4 is highly expressed in neutrophils (Heng and Painter, 2008; Database, 2014) , and indeed, we observed high levels of AGS4 expression in primary mouse neutrophils ( Figure 5A ). Therefore, we measured chemotactic responses in primary neutrophils from WT and AGS4/Gpsm3-null mice, and observed significant defects in AGS4/Gpsm3-null neutrophil chemotaxis to fMLP ( Figure 5B ). Interestingly, the chemotactic defect observed was dose-dependent, with a ~60% reduction in directed migration to the highest dose of agonist ( Figure 5B ), suggesting AGS4/Gpsm3 may play a role in shaping cell responses at high levels of receptor activation. We next asked if the requirement of AGS4/Gpsm3 for proper neutrophil chemotaxis ex vivo was also observed in vivo. As an initial approach to address this question, we used an induced peritonitis model by intraperitoneal injection of thioglycollate to measure the recruitment of neutrophils to the site of inflammation. While induced peritonitis resulted in a significant accumulation of WT neutrophils in the IP cavity, the level of AGS4/Gpsm3-null neutrophils recruited to the IP cavity was reduced by ~80%
( Figure 5C , left panel). Levels of neutrophils in the blood and bone marrow were not different between WT and AGS4/Gpsm3-null mice ( Figure 5C , center and right panels). These data suggest a possible deficiency in extravasation or a tardive response in AGS4/Gpsm3-null neutrophils. Alterations in circulating populations of neutrophils and lymphocytes in AGS4/Gpsm3-null mice may suggest a defect either in the production or differentiation of these cells or a defect in their egress from the bone marrow into the circulation. Interestingly, similar phenotypes including mild neutropenia and a defect in neutrophil migration were also observed in mice with an RGS-insensitive Gnai2 knock-in allele (Cho et al., 2012) , suggesting that regulation of the duration of G-protein signaling subsequent to chemoattractant exposure is critical in neutrophil mobility and recruitment to sites of inflammation.
DISCUSSION
Our initial approach to investigating the role of AGS4 in chemokine signal processing reported in this manuscript utilized key prototype chemokine and chemoattractant receptors. AGS4 may possess selectivity for modulating G-protein signal processing for different chemokine receptors and this is the basis for future studies. We have shown here that AGS4 forms a Gi-dependent complex with the chemokine receptor CXCR4 that is regulated by agonist (Figure 1 ). Based on data presented here and elsewhere, this agonist regulation is likely due to the apparent coupling of the Gi-AGS4 complex directly with the agonist-bound GPCR (Robichaux et al., 2015) . While our data indicate defective chemokine signal integration from CXCR4 activation upon loss of AGS4 expression in dendritic cells and lymphocytes, we cannot rule out a potential role for CXCR7, which can also bind CXCL12. However, CXCR7-mediated responses to CXCL12 are G-protein independent (Burns et al., 2006; Zabel et al., 2009; Rajagopal et al., 2010) , thus likely limiting the direct involvement of G-protein modulators like AGS4 in CXCLX12/CXCR7-mediated signaling. There are also reports of potential CXCR4-CXCR7 dimerization (Levoye et al., 2009; Decaillot et al., 2011) ; thus the interplay between these two receptors and the influence AGS4 may have on such a complex may be of future interest.
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We previously demonstrated that the Gi-GPR module can be regulated by a 7TMR (Oner et al., 2010a; Oner et al., 2010b; Robichaux et al., 2015) . Recently, we reported that this regulation reflects a direct engagement of Gi-GPR with the 7TMR analogous to canonical G. It is possible that direct input from chemoattractant receptors to the Gi-AGS4 module may play an important modulatory role in chemokine signal processing, and the loss of this alternative mode of signal input to Gi signaling may be responsible for the defects observed in AGS4/Gpsm3-null leukocytes. Such regulation would be a novel mechanism for G-protein signal processing, as Gi-specific roles in chemoattractant signal processing have been elusive. However, there are reports suggesting Gi-specific functions in leukocyte responses to chemokines (Surve et al., 2016) . While G is generally considered the primary G-protein signaling unit within leukocytes (Arai et al., 1997; Neptune and Bourne, 1997; Peracino et al., 1998; Lehmann et al., 2008; Zhang et al., 2010) , (e.g. elevations in intracellular Ca 2+ , activation of PI3K and downstream activation of small GTPases required for directed migration) Surve et al. (Surve et al., 2016) recently reported that Gi signaling in leukocytes appears to be required to locally counteract G-mediated increases in cAMP to facilitate cell polarity and directed migration. We speculate that the Gi-AGS4 module, and perhaps Gi-AGS3 complexes as well (Blumer and Lanier, 2014; Branham-O'Connor et al., 2014; Robichaux et al., 2015) , by coupling directly with chemokine receptors, may increase the available pool of Gi-GTP to assist in dampening local cAMP levels to facilitate leukocyte polarity and directed migration.
Within the immune system, AGS4 is highly expressed in neutrophils (Fig. 5) , perhaps higher than any other immune cell type (Heng and Painter, 2008; Database, 2014) , which suggests an important role for AGS4 in neutrophils and also provides an attractive model for studying the role of AGS4 in the innate immune system. The apparent dose-dependent chemotactic defect observed in AGS4/Gpsm3-null neutrophils ( Figure 5B ) suggests that AGS4 may play an important role in modulating cellular responses at higher levels of receptor activation. Similar observations were noted for regulator of G-protein signaling 1 (RGS1), another accessory protein important for chemokine-regulated G-protein signal processing (Han et al., 2006; Hwang et al., 2010) . Furthermore, our data indicate that AGS4-null neutrophils have a defect in chemoattractant-mediated migration ex vivo, which manifests in a defect in neutrophil recruitment to sites of inflammation in vivo (Fig. 5) . It is interesting to note that either inhibition or loss of Gi 2 expression in leukocytes and endothelial cells also impairs neutrophil extravasation to sites of inflammation (Warnock et al., 1998; Pero et al., 2007; Zarbock et al., 2007; Wiege et al., 2012) . Thus, aberrant transmigration of AGS4/Gpsm3-null neutrophils from the blood to the IP cavity may reflect simultaneous aberrant Gi 2 signaling in both neutrophils and endothelial cells, which together contribute to the observed defects in innate immunity. Future studies are aimed at validating these results in primary human leukocytes. Taken together, these data suggest that AGS4 may play a role in the inflammatory response and that the AGS4 -Gi module may be an attractive target for the development of potential therapeutics.
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